Trademark Overview
On Thursday, August 8, 2024, a trademark application was filed for TUBULIS with the United States Patent and Trademark Office. The USPTO has given the TUBULIS trademark a serial number of 98688540. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 8, 2024. This trademark is owned by Tubulis GmbH. The TUBULIS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; antibody-drug conjugates; pharmaceutical and veterinary preparations comprising small molecules; small molecule compounds for treatment of cancer.
Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use.
Scientific services and research relating thereto in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.